title: Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion.
abstract: Full and functionally selective M1 muscarinic agonists (carbachol and AF102B, respectively) activate secretion of the soluble form of amyloid precursor protein (APPs) in PC12 cells expressing the m1 muscarinic receptor (PC12M1 cells). This activation is further augmented by neurotrophins such as nerve growth factor and basic fibroblast growth factor. Muscarinic stimulation activates two transduction pathways that lead to APPs secretion: protein kinase C (PKC)-dependent and mitogen-activated protein kinase (MAPK)-dependent pathways. These pathways operate in parallel and converge with transduction pathways of neurotrophins, resulting in enhancement of APPs secretion when both muscarinic agonist and neurotrophins stimulate PC12M1 cells. These conclusions are supported by the following findings: (a) Only partial blockade of APPs secretion is observed when PKC, p21ras, or MAPK is fully inhibited by their respective specific inhibitors, GF109203X, S-trans, trans-farnesylthiosalicylic acid, and PD98059. (b) K252a, which blocks PKC and phorbol 12-myristate 13-acetate-induced APPs secretion, enhances both muscarinic-stimulated MAPK activation and APPs secretion. (c) Activation of MAPK in PC12M1 cells by muscarinic agonists is Ras-dependent but PKC-independent and is enhanced synergistically by neurotrophins. These results suggest that muscarinic stimulation of APPs secretion is mediated by at least two independent pathways that converge and enhance the signal for APPs secretion at the convergence point.
authors.affiliation: Israel Institute for Biological Research, Ness-Ziona.
authors.forename: R
authors.initials: R
authors.lastname: Haring
authors.forename: A
authors.initials: A
authors.lastname: Fisher
authors.forename: D
authors.initials: D
authors.lastname: Marciano
authors.forename: Z
authors.initials: Z
authors.lastname: Pittel
authors.forename: Y
authors.initials: Y
authors.lastname: Kloog
authors.forename: A
authors.initials: A
authors.lastname: Zuckerman
authors.forename: N
authors.initials: N
authors.lastname: Eshhar
authors.forename: E
authors.initials: E
authors.lastname: Heldman
mesh_terms: D016564:Amyloid beta-Protein Precursor / Q000378:metabolism*; D000818:Animals; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D002227:Carbazoles / Q000494:pharmacology; D004357:Drug Synergism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D026121:Indole Alkaloids; D018721:Muscarinic Agonists / Q000494:pharmacology; D009414:Nerve Growth Factors / Q000494:pharmacology; D016716:PC12 Cells; D010766:Phosphorylation; D011233:Precipitin Tests; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000502:physiology*; D051381:Rats; D011976:Receptors, Muscarinic / Q000378:metabolism*; D014443:Tyrosine / Q000378:metabolism
chemical_list: D016564:Amyloid beta-Protein Precursor; D002227:Carbazoles; D004791:Enzyme Inhibitors; D026121:Indole Alkaloids; D018721:Muscarinic Agonists; D009414:Nerve Growth Factors; D011976:Receptors, Muscarinic; D014443:Tyrosine; C049985:staurosporine aglycone; D011493:Protein Kinase C; D017871:Calcium-Calmodulin-Dependent Protein Kinases